Biosimilars Development Strategies: Fast to Market Approaches - Image 1

Price loading...

CRC Press Biosimilars Development Strategies: Fast to Market Approaches

Name: Biosimilars Development Strategies: Fast to Market Approaches
Brand: CRC Press

Pharmacy - Dispensing

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

After 18 years since the first biosimilar was approved, a lot has changed, from the regulatory guidelines to the stakeholder perceptions about the safety and efficacy of biosimilars. However, the development costs remain high, preventing faster entry into markets with more than 200 choices. Analyzing the regulatory filings of all approved biosimilars in the US and EU, a deep analysis of the scientific principles, and continuous challenges to the regulatory authorities have made it possible to plan the development on a fast track. This book teaches how to cut the current time and cost by more than 70%, based on the author's hands-on experience. Features: Describes the emergence of biosimilars since the first publication of the recombinant engineering patent, as well as a listing of all approved recombinant products, their patent expiry and their adoption across the globe. Provides a better understanding of the safety and efficacy of approved biosimilars. Global approval requires accommodating guidelines and detailed planning to avoid redundancy as well as high costs. The basic expectations of the agencies are presented here. Presents a detailed analysis of all EU and FDA-approved products with a comparative analysis. Renowned author and entrepreneur in the field of drug discovery and production.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 1032517018
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 15 July 2024
Listed Since: 25 January 2024

Barcode

No barcode data available

CRC Press Biosimilars Development Strategies: Fast to Market Approaches

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

Biopharmaceuticals: Challenges and Opportunities

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

CRC Press - Biosimilar Drug Product Development Book

Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)

Biosimilars and Interchangeable Biologics: Strategic Elements

Handbook of Bioequivalence Testing (Drugs and the Pharmaceutical Sciences)

Developability of Biotherapeutics: Computational Approaches

Analytical Similarity Assessment in Biosimilar Product Development

Methodologies in Biosimilar Product Development (Chapman & Hall/CRC Biostatistics Series)

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

mRNA Therapeutics: Fast-to-Market Strategies

Wiley - Biological Drug Products: Development and Strategies

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Pharmaceutical Product Development: Insights Into Pharmaceutical Processes, Management and Regulatory Affairs